Control of psychomotor agitation and aggressive behavior in patients with autistic disorder: A retrospective chart review

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 3 B, 2008, Pages 646-651

  Novaes, Camila Marinho ^a,c   Pondé, Milena Pereira ^a   Freire, Antonio Carlos Cruz ^b  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Federal University of Bahia ^*  (Brazil)

Author keywords

Antipsychotics; Autistic disorder; Pharmacological; Retrospective; Treatment

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADOLESCENT; ADULT; AGGRESSION; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; MONOTHERAPY; OUTPATIENT; PSYCHOPHARMACOTHERAPY; RESTLESSNESS; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 56049123920     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000500008     Document Type: Article

References (32)

1. th Ed. Washington, DC: American Psychiatric Association, 2000.
2. Rapin I. Autistic children: diagnosis and clinical features. Pediatrics 1991;87:751-760.
3. Sprovieri MHS, Assumpção FB Jr. Dinâmica familiar de crianças autistas. Arq Neuropsiquiatr 2001;59:230-237.
4. nd Ed. New Jersey: Lawrence Erlbaum Associate Publishers, 1999.
5. Machado MG, Oliveira HA, Cipolotti R, et al. Anatomical and functional abnormalities of central nervous system in autistic disorder: a MRI and SPECT study. Arq Neuropsiquiatr 2003;61:957-961.
6. Weller EB, Rowan A, Elia J, Weller RA. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders. Psychiatry De J Clin 1999;60(Suppl):S5-S11.
7. Korkmaz B. Infantile autism: adult outcome. Semin Clin Neuropsychiatry 2000;5:164-170.
8. Moura AMR, Menezes APA, Pondé MP. Atualização na farmacoterapia do autismo. In: Garcia R, Pondé MP, Lima MG (Eds.). Atualização em psicoses. São Paulo: Phoenix, 2004:235-244.
9. Campbell M, Anderson LT, Meier M, et al. A comparison of haloperidol and behavior therapy and their interaction in autistic children. J Am Acad Child Adolesc Psychiatry 1978;17:640-655.
10. Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 1984;141:1195-1202.
11. Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 1989;19:227-239.
12. Campbell M, Armenteros JL, Malone RP, Adams PB, Eiesenberg ZW, Overall JE. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 1997;36:835-843.
13. Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008;21:151-156.
14. Findling RL, Schulz SC, Reed MD, Blumer JL. The antipsychotics: a pediatric perspective. Pediatr Clin North Am 1989;45:1205-1232.
15. Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol 2008;18:157-178.
16. Gesell A, Amatruda. Diagnóstico do desenvolvimento: avaliação e tratamento do desenvolvimento neuropsicológico do lactente e da criança pequena, o normal e o patológico. Ed. 3. São Paulo: Atheneu, 2000.
17. Guy W . ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare. Washington DC: Publication ADM, 1976:534-537.
18. Rutter M, Schopler E. Classification of pervasive developmental disorders: some concepts and practical considerations. J Autism Dev Disord 1992;22:459-482.
19. Malone RP, Gratz SS, Delaney MA, Hyman SB. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs 2005;19:923.
20. Chavez B, Chavez-Brown M, Rey JA. Role of risperidone in children with autism spectrum disorder. Ann Pharmacother 2006;40:909-916.
21. Troost PW, Lahuis BE, Steenhuis MP, et al. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry 2005;44:1137.
22. Mukaddes NM. Short-term efficacy and safety of risperidone in young children with autistic disorder (AD). World J Biol Psychiatry 2004;5:211-214.
23. Research Units on Pediatric Psychopharmacology Autism Network. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry 2005;162:1361-1369.
24. Stachnik JM, Nunn-Thompson C. Use of atypical antipsychotics in the treatment of autistic disorder. Ann Pharmacother 2007;41:626-634.
25. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol 1999;19:37-44.
26. McDougle CJ. Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry 2002;41:921-927.
27. Martin A, Koenig K, Scahill L, Bregman J. Open-label quetiapine in the treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 1999;9:99-107.
28. Hellings JA, Kelley LA, Gabrielli WF, Kilgore E, Shah P. Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry 1996;57:333-336.
29. Turgay A. Aggression and disruptive behavior disorders in children and adolescents. Expert Rev Neurother 2004;4:623-632.
30. Rocha AF, Leite CC, Rocha FT, et al. Mental retadation: a MRI study of 146 Brazilian children. Arq Neuropsiquiatr 2006;64:186-192.
31. Horrigan JP, Barnhill LJ. Risperidone and explosive aggressive autism. J Autism Dev Disord 1997;27:313-323.
32. Aldred C, Green J, Adams C. A new social communication intervention for children with autism: pilot randomised controlled treatment study suggesting effectiveness. J Child Psychol Psychiatry 2004;45:1420-1430.